Depreciation of PLIANT THERAPEUTICS, INC. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
PLIANT THERAPEUTICS, INC. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • PLIANT THERAPEUTICS, INC. Depreciation for the quarter ending 30 Sep 2025 was $400,000, a 20% decline year-over-year.
  • PLIANT THERAPEUTICS, INC. Depreciation for the twelve months ending 30 Sep 2025 was $1,760,000, a 16% decline year-over-year.
  • PLIANT THERAPEUTICS, INC. annual Depreciation for 2024 was $2,125,000, a 15% increase from 2023.
  • PLIANT THERAPEUTICS, INC. annual Depreciation for 2023 was $1,841,000, a 0.99% increase from 2022.
  • PLIANT THERAPEUTICS, INC. annual Depreciation for 2022 was $1,823,000, a 19% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,760,000 $400,000 -$100,000 -20% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,860,000 $400,000 -$200,000 -33% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $2,060,000 $448,000 -$65,000 -13% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $2,125,000 $512,000 +$23,000 +4.7% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q3 2024 $2,102,000 $500,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $2,102,000 $600,000 +$200,000 +50% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $1,902,000 $513,000 +$61,000 +13% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $1,841,000 $489,000 +$21,000 +4.5% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $1,820,000 $500,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $1,820,000 $400,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $1,820,000 $452,000 -$3,000 -0.66% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q4 2022 $1,823,000 $468,000 +$92,000 +24% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $1,731,000 $500,000 +$100,000 +25% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,631,000 $400,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $1,631,000 $455,000 +$96,000 +27% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $1,535,000 $376,000 -$22,000 -5.5% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $1,557,000 $400,000 +$100,000 +33% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $1,457,000 $400,000 +$100,000 +33% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $1,357,000 $359,000 +$47,000 +15% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $1,310,000 $398,000 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $300,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $300,000 +$100,000 +50% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $312,000 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q3 2019 $300,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $200,000 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2

PLIANT THERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,125,000 +$284,000 +15% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
2023 $1,841,000 +$18,000 +0.99% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $1,823,000 +$288,000 +19% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $1,535,000 +$225,000 +17% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $1,310,000 +$197,000 +18% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $1,113,000 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.